Obesity in childhood cancer survivors

Pediatric Endocrinology Reviews

Volumn 3, Issue SUPPL. 2, 2006, Pages 306-311

  Lustig, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain Tumor; Hypothalamus; Insulin; Late Effects; Leukemia; Obesity; Octreotide; Risk of Obesity After Cancer Therapy; Vagus

Indexed keywords

GLUCAGON; INSULIN; OCTREOTIDE; RECEPTOR BLOCKING AGENT; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

BRAIN TUMOR; CANCER SURGERY; CANCER SURVIVOR; CHILDHOOD CANCER; CLINICAL TRIAL; ENERGY BALANCE; ENERGY EXPENDITURE; HIGH RISK POPULATION; HORMONE ACTION; HUMAN; HYPOTHALAMUS; INSULIN RELEASE; LEUKEMIA; NEGATIVE FEEDBACK; OBESITY; ORAL GLUCOSE TOLERANCE TEST; ORGAN INJURY; QUALITY OF LIFE; REVIEW; SIGNAL TRANSDUCTION;

EID: 33646240044     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Didi M, Didcock E, Davies HA, Oligvy-Stuart AL, Wales JKH, Shalet SM. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia of childhood. J Pediatr 1995;127:63-67
2. Mayer EI, Reuter M, Dopfer RE, Ranke MB. Energy expenditure, energy intake, and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm Res 2000;53:193-199
3. Sainsbury CP, Newcombe RG, Hughes IA. Weight gain and height velocity during prolonged first remission from acute lymphoblastic leukaemia. Arch Dis Child 1985;60:832-836
4. Zee P, Chen CH. Prevalence of obesity in children after therapy for acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 1986;8:294-299
5. Schell MJ, Ochs JJ, Schriock EA, Carter M. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 1992;10:128-133
6. Odame I, Reilly JJ, Gibson BE, Donaldson MD. Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia. Arch Dis Child 1994;71:147-149
7. Craig F, Leiper AD, Stanhope R, Brain C, Meller ST, Nussey SS. Sexually dimorphic and radiation dose-dependent effect of cranial irradiation on body mass index. Arch Dis Child 1999;81:500-504
8. Sklar CA, Mertens AC, Walter A, Mitchell D, Nesbit M, O'Leary M, Hutchinson R, Meadows AT, Robison LL. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol 2000;35:91-95
9. Nysom K, Holm K, Michaelsen KF, Hertz H, Müller J, Molgaard C. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 1999;84:4591-4596
10. Ross JA, Oeffinger KC, Davies SM, Mertens AC, Langer EK, Kiffmeyer WR, Sklar CA, Stovall M, Yasui Y, Robison LL. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2004;2:3558-3562
11. Lustig RH, Post SR, Srivannoboon K, Rose SR, Danish RK, Burghen GA, Wu S, Xiong K, Merchant TE. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 2003;88:611-616
12. Meacham LR, Gurney JG, Mertens AC, Ness KK, Sklar CA, Robison LL, Oeffinger KC. Body mass index in long-term adult survivors of childhood cancer: a report of the Childhood Cancer Survivors Study (CCSS). Cancer 2005;103:1730-1739
13. Gurney JG, Kadan-Lottick NS, Packer RJ, Neglia JP, Sklar CA, Punyko JA, Stovall M, Yasui Y, Nicholson HS, Wolden S, McNeil DE, Mertens AC, Robison LL. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003;97:663-673
14. Stahnke N, Grubel G, Lagenstein I, Willis KP. Long-term follow-up of children with craniopharyngioma. Eur J Pediatr 1984;142:179-185
15. Sorva R. Children with craniopharyngioma: early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 1988;77:587-592
16. Pinto G, Bussieres L, Recasens C, Souberbielle JC, Zerah M, Brauner R. Hormonal factors influencing weight and growth pattern in craniopharyngioma. Horm Res 2000;53:163-169
17. Babinski MJ. Tumeur du corps pituitaire san acromegalie et avec arret de developpement des organes genitaux. Rev Neurol 1900;8:531-533
18. Frohlich A. Ein fall von tumor der hypophysis cerebri ohne akromegalie. Weiner Klin Rdsch 1901;15:883-886
19. Lustig RH. Hypothalamic obesity: the sixth cranial endocrinopathy. Endocrinologist 2002;12:210-217
20. Bray CA, Gallagher TF. Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature. Medicine 1975;54:301-333
21. Bray GA. Syndromes of hypothalamic obesity in man. Pediatr Ann 1984;13:525-536
22. Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sorenson N. Longitudinal study of growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 2004;89:3298-3305
23. Elmquist JK, Elias CF, Saper CB. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999;22:221-232
24. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D. Insulin and the central regulation of energy balance: Update 1994. Endocrin Rev 1994;2:109-113
25. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660
26. 3-36 physiologically inhibits food intake. Nature 2002;418:650-654
27. Lustig RH. The neuroendocrinology of obesity. Endocrinol Metab Clin North Am 2001;30:765-785
28. g coactivator-1. Biochem Biophys Res Commun 1999;261:870-876
29. Lowell BB, Spiegelman BM. Towards a molecular understanding of adaptive thermogenesis. Nature 2000;404:652-660
30. Lustig RH. The neuroendocrinology of childhood obesity. Pediatr Clin North Am 2001;48:909-930
31. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999;20:68-100
32. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-671
33. Elmquist JK, Ahima RS, Elias CF, Flier JS, Saper CB. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci USA 1998;95:741-746
34. Small CJ, Bloom SR. Gut hormones and the control of appetite. Trends Endocrinol Metab 2004;15:259-263
35. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000;141:4797-4800
36. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407:908-913
37. Satoh N, Ogawa Y, Katsuura G, Tsuji T, Masuzaki H, Hiraoka J, Okazaki T, Tamaki M, Hayase M, Yoshimasa Y, Nishi S, Hosoda K, Nakao K. Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 1997;138:947-954
38. Thornton JE, Cheung CC, Clifton DK, Steiner RA. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997;138:5063-5066
39. Marin P, Russeffé-Scrive A, Smith J, Bjorntorp P. Glucose uptake in human adipose tissue. Metabolism 1988;36:1154-1164
40. Powley TL, Laughton W. Neural pathways involved in the hypothalamic integration of autonomic responses. Diabetologia 1981;20:378-387
41. D'Alessio DA, Kieffer TJ, Taborsky GJ, Havel PJ. Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques. J Clin Endocrinol Metab 2001;86:1253-1259
42. Lee HC, Curry DL, Stern JS. Direct effect of CNS on insulin hypersecretion in obese Zucker rats: involvement of vagus nerve. Am J Physiol 1989;256:E439-E444
43. Gilon P, Henquin JC. Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr Rev 2001;22:565-604
44. Lustig RH. Autonomic dysfunction of the β-cell and the pathogenesis of obesity. Rev Endocrine Metab Disord 2003;4:23-32
45. 2+ pools. Biochem Biophys Res Commun 1996;224:67-73
46. Zawalich WS, Zawalich KC, Rasmussen H. Cholinergic agonists prime the β-cell to glucose stimulation. Endocrinology 1989;125:2400-2406
47. Nishi S, Seino Y, Ishida H, Seno M, Taminato T, Sakurai H, Imura H. Vagal regulation of insulin, glucagon, and somatostatin secretion in vitro in the rat. J Clin Invest 1987;79:1191-1196
48. Berthoud HR, Jeanrenaud B. Acute hyperinsulinemia and its reversal by vagotomy following lesions of the ventromedial hypothalamus in anesthetized rats. Endocrinology 1979;105:146-151
49. Komeda K, Yokote M, Oki Y. Diabetic syndrome in the Chinese hamster induced with monosodium glutamate. Experientia 1980;36:232-234
50. Rohner-Jeanrenaud F, Jeanrenaud B. Consequences of ventromedial hypothalamic lesions upon insulin and glucagon secretion by subsequently isolated perfused pancreases in the rat. J Clin Invest 1980;65:902-910
51. Tian YM, Urquidi V, Ashcroft SJ. Protein kinase C in β-cells: expression of multiple isoforms and involvement in cholinergic stimulation of insulin secretion. Mol Cell Endocrin 1996;119:185-193
52. Arbuzova A, Murray D, McLaughlin S. MARCKS, membranes, and calmodulin: kinetics of their interaction. Biochim Biophys Acta 1998;1376:369-379
53. 2+ store in secretory granules of insulin-producing cells. J Bio Chem 1994;269:27167-27170
54. Rocca AS, Brubaker PL. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999;140:1687-1694
55. Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev 1999;20:876-913
56. Geffner ME. The growth without growth hormone syndrome. Endocrin Metab Clin North Am 1996;25:649-663
57. Olney RC, Mougey EB. Expression of the components of the insulin-like growth factor axis across the growth plate. Mol Cell Endocrinol 1999;156:63-71
58. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE. Hypothalamic obesity in children caused by cranial insult: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 1999;135:162-168
59. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrol Metab 2003;88:2586-2592
60. Preeyasombat C, Bacchetti P, Lazar AA, Lustig RH. Racial and etiopathologic dichotomies in insulin secretion and resistance in obese children. J Pediatr 2005;146:474-481
61. Smith DK, Sarfeh J, Howard L. Truncal vagotomy in hypothalamic obesity. Lancet 1983;1:1330-1331
62. Fobi MA. Operations that are questionable for the control of obesity. Obes Surg 1993;3:197-200
63. Mason PW, Krawiecki N, Meacham LR. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 2002;156:887-892
64. Molloy PT, Berkowitz R, Stallings VA, Krell H, Sutton LN, Vaughan SN, Loeb N, Phillips PC. Pilot study of evaluation and treatment of tumor-related obesity in pediatric patients with hypothalamic/chiasmatic gliomas and craniopharyngiomas. 1988 International Pediatric Oncology Meeting Rome, Italy:156.
65. + channels in the beta-cell. J Biol Chem 1991;266:837-843
66. Mitra SW, Mezey E, Hunyady B, Chamberlain L, Hayes E, Foor F, Wang Y, Schonbrunn A, Schaeffer JM. Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic β-cells. Endocrinology 1999;140:3790-3796
67. Lamberts SW, Van Der Lely AJ, De Herder WW, Hofland LJ. Octreotide. N Eng J Med 1996;334:246-254
68. Bertoli A, Magnaterra R, Borboni P, Marini MA, Barini A, Fusco A, Bollea MR. Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity. Horm Res 1998;49:17-21
69. Sanford RA. Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg 1994;21(supp):39-43
70. Eisenstat DD. Craniopharyngioma. Curr Treat Options Neurol 2001;3:77-88